No abstract available
Keywords:
Adipex-P; Belviq; Contrave; Lomaira; Qsymia; Saxenda; Xenical; benzphetamine; bupropion; diethylpropion; liraglutide; lorcaserin; naltrexone; orlistat; phendimetrazine; phentermine; phentermine/topiramate; weight loss.
MeSH terms
-
Anti-Obesity Agents / adverse effects
-
Anti-Obesity Agents / therapeutic use*
-
Drug Approval*
-
Humans
-
Obesity / diagnosis
-
Obesity / drug therapy*
-
Obesity / physiopathology
-
United States
-
United States Food and Drug Administration*